Advancements of molecular imaging and radiomics in pancreatic carcinoma

Xiao-Xi Pang; Liang Xie; Wen-Jun Yao; Xiu-Xia Liu; Bo Pan; Ni Chen

doi:10.4329/wjr.v15.i1.10

Advancements of molecular imaging and radiomics in pancreatic carcinoma

World J Radiol. 2023 Jan 28;15(1):10-19. doi: 10.4329/wjr.v15.i1.10.

Authors

Xiao-Xi Pang¹, Liang Xie¹, Wen-Jun Yao², Xiu-Xia Liu¹, Bo Pan³, Ni Chen⁴

Affiliations

¹ Department of Nuclear Medicine, The Second Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China.
² Department of Radiology, The Second affiliated hospital of Anhui Medical University, Hefei 230601, Anhui Province, China.
³ PET/CT Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, Anhui Province, China.
⁴ Department of Nuclear Medicine, School of Basic Medicine Anhui Medical University, Hefei 230032, Anhui Province, China. icefei@mail.ustc.edu.cn.

Abstract

Despite the recent progress of medical technology in the diagnosis and treatment of tumors, pancreatic carcinoma remains one of the most malignant tumors, with extremely poor prognosis partly due to the difficulty in early and accurate imaging evaluation. This paper focuses on the research progress of magnetic resonance imaging, nuclear medicine molecular imaging and radiomics in the diagnosis of pancreatic carcinoma. We also briefly described the achievements of our team in this field, to facilitate future research and explore new technologies to optimize diagnosis of pancreatic carcinoma.

Keywords: Artificial intelligence; Magnetic resonance imaging; Molecular imaging; Pancreatic carcinoma; Positron emission tomography-computed tomography; Positron emission tomography-magnetic resonance.

Publication types

Review